We challenge long-held beliefs about fibroids, highlight new ectopic pregnancy nuances, and dig into real-world dermoid cyst outcomes. We also unpack the evidence and ethics of 39-week induction after IVF and ICSI, balancing small absolute risks with maternal tradeoffs.

• Evidence overturning links between fibroids and miscarriage, PROM and abruption
• Distinguishing spontaneous versus iatrogenic preterm birth in fibroid pregnancies
• Why myomectomy can raise early delivery and cesarean rates in some patients
• Ectopic care updates: tube-sparing choices, HCG thresholds, two-dose methotrexate
• Experimental adjuncts to methotrexate remain unproven
• Dermoid data supporting laparoscopy, irrigation, and specimen bags over open surgery
• Surgical decision making during pregnancy and avoiding uterine manipulators
• IVF and ICSI timing: late stillbirth risk signals, limits of testing, 39-week logic
• Shared decision making when absolute risks are low but values differ

Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram

1:33 Fibroids And Miscarriage Myths

5:53 Preterm Birth, PROM, And Hemorrhage

9:31 Myomectomy: Risks, Scars, And Outcomes

13:25 Ectopic Pregnancy: What’s New

18:37 Surgery Versus Methotrexate Nuances

22:05 Experimental Add-Ons To Medical Therapy

27:47 Dermoid Cysts: Real-World Data

32:48 Laparoscopy, Spillage, And Pregnancy

36:06 When Open Surgery Makes Things Worse

40:34 IVF, ICSI, And 39-Week Induction

48:05 Stillbirth Risk: What The Data Shows

55:20 Testing, Timing, And Shared Decisions

1:04:10 Practical Counseling And Tradeoffs

Follow us on Instagram @thinkingaboutobgyn.